NPY1 Receptor Agonist Modulates Development of Depressive-Like Behavior and Gene Expression in Hypothalamus in SPS Rodent PTSD Model

Overview of attention for article published in Frontiers in Neuroscience, April 2017

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 40 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 24 publications that cite this research output.

24

The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.

Enhancing Cognitive Functions and Neuronal Growth through NPY1R Agonist and Ketamine Co-Administration: Evidence for NPY1R-TrkB Heteroreceptor Complexes in Rats

Article in Cells (April 2024)

Long‐term enhancements in antidepressant efficacy and neurogenesis: Effects of intranasal co‐administration of neuropeptide Y 1 receptor (NPY1R) and galanin receptor 2 (GALR2) agonists in the ventral hippocampus

Article in The FASEB Journal (April 2024)

Potentiation of antidepressant effects: NPY1R agonist and ketamine synergy enhances TrkB signaling and neurogenesis in the ventral hippocampus

Article in Expert Opinion on Therapeutic Targets (April 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.